South African officials report 'much lower rate' of hospital admissions during Omicron wave
In a rare bit of good news to come out of the current Omicron variant-driven COVID-19 wave, South Africa, where the new, highly-transmissible strain was first detected, reported on Friday "a much lower rate of hospital admissions" as well as "signs that the wave of infections might be peaking," Bloomberg reports.
Only 1.7 percent of identified COVID-19 cases were admitted to the hospital in the second week of infections of this fourth wave, versus 19 percent in the second week of the third, Delta variant-driven wave, said South African Health Minister Joe Phaahla at a press conference.
Officials also shared evidence that "the strain may be milder, and that infections may already be peaking in the country's most populous province, Gauteng," writes Bloomberg.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
All that said, however, new cases in week two of this fourth wave were over 20,000 a day, "compared with 4,400 in the same week of the third wave."
Also reportedly inflating this wave's hospitalization rate is the fact that "milder patients are being admitted because there is room to accommodate them," Bloomberg writes, per officials; some admittants are even there for other complaints. There are currently about 7,600 people hospitalized with COVID in South Africa, which is about 40 percent of the peak in the second and third waves.
"We have seen a decrease in a proportion of people who need to be on oxygen," said Waasila Jassat, a researcher with the National Institute for Communicable Diseases, at the press conference. "They are at very low levels."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Ukraine hints at end to 'hot war' with Russia in 2025
Talking Points Could the new year see an end to the worst European violence of the 21st Century?
By Rafi Schwartz, The Week US Published
-
What does the FDIC do?
In the Spotlight Deposit insurance builds confidence in the banking system
By Joel Mathis, The Week US Published
-
2024: The year of conspiracy theories
IN THE SPOTLIGHT Global strife and domestic electoral tensions made this year a bonanza for outlandish worldviews and self-justifying explanations
By Rafi Schwartz, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published